Filing Details

Accession Number:
0001209191-21-029341
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-30 13:00:00
Reporting Period:
2021-04-28
Accepted Time:
2021-04-30 17:49:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1348911 Kalvista Pharmaceuticals Inc. KALV Pharmaceutical Preparations (2834) 200915291
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1777800 David Michael Smith C/O Kalvista Pharmaceuticals, Inc
55 Cambridge Parkway, Suite 901E
Cambridge MA 02142
Senior Vp, Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-28 10,014 $8.39 10,014 No 4 M Direct
Common Stock Disposition 2021-04-28 10,014 $25.76 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-04-28 10,014 $0.00 10,014 $8.39
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,096 2026-11-21 No 4 M Direct
Footnotes
  1. The option is fully vested.